May MIMS update

A look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Product Nelarabine (Nelarabine‑Reach) is a pro‑drug of the deoxyguanosine analogue ara‑G. Nelarabine is rapidly demethylated by adenosine deaminase (ADA) to ara‑G and then phosphorylated intracellularly by deoxyguanosine kinase and deoxycytidine kinase to its 5'‑monophosphate metabolite. The